Prognosis and Prognostic Factors of Serous Borderline Tumor-Micropapillary Variant: Retrospective Study of 200 Patients with Long-Term Follow-Up

Figure 1

Survival curves in women with serous borderline ovarian tumor-micropapillary variants (SBOT-Ms).

(a) Disease-free survival (DFS) according to treatment modalities

(b) Invasive DFS according to treatment modalities

(c) Overall survival according to treatment modalities

(d) DFS according to stage groups and type of implants

(e) Invasive DFS according to stage groups and type of implants

(f) Overall survival according to stage groups and type of implants